Amedisys Inc Stock News

BATON ROUGE, La., May 03, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has closed on its acquisition of regulatory ass

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q1 2021 Results - Earnings Call Transcript

BATON ROUGE, La., April 27, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, in collaboration with Sound Physicians, a leading phys

Amedisys (NASDAQ:AMED) announces its next round of earnings this Wednesday, April 28. Here is Benzinga's everything-that-matters guide for this Wednesday's Q1 earnings announcement.

Growth in Home Health and Hospice along with recent innovation and acquisitions is expected to have contributed to Amedisys (AMED) top-line growth in Q1.

SPARTANBURG, S.C.--(BUSINESS WIRE)-- #hospice--Agape Care Group Appoints Carry vandenMaagdenberg as Its Chief Technology and Innovation Officer and Matt Winer to Chief Operations Officer Post

Amedisys' (AMED) new agreement to acquire Randolph Country regulatory assets will broaden the company's footprint in the Home Health care market.

BATON ROUGE, La., April 14, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, will report results for the first quarter ended March

BATON ROUGE, La., April 14, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has signed a definitive agreement to acquire

Biden's support to expand access to long-term care services under Medicaid bodes well for companies providing home healthcare.

Amedisys delivers another strong quarter despite regulatory shifts and COVID-19-related headwinds.

BATON ROUGE, La., March 01, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Ch

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q4 2020 Results - Earnings Call Transcript

Amedisys (AMED) fourth-quarter 2020 revenues improve year over year, driven by strong growth across the Home Health and Hospice divisions.

Shares of Amedisys (NASDAQ:AMED) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 58.51% over the past year to $1.49, which beat